Anixa (ANIX) CEO Amit Kumar Buys 3,000 Shares

What Happened

• Amit Kumar, CEO of Anixa Biosciences, acquired 3,000 common shares on 2026-09-10 at $2.75 per share, for a total purchase amount of $8,250. The Form 4 lists the transaction as a purchase (code P — open market or private purchase), which is a direct insider buy rather than a sale.

Key Details

• Transaction date: 2026-09-10; Filing date (Accession): 2026-09-14 (Form 4 accession 0001493152-26-042512).
• Price: $2.75 per share; Total value: $8,250.
• Transaction type: Purchase (Form 4 code P — open market or private purchase).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• No footnotes, 10b5-1 plan, tax-withholding, or late-filing flag were indicated in the provided details.

Context

• Insider purchases are often watched by investors as a sign that an insider is willing to put personal capital into the company; this was a modest open-market/private purchase rather than an option exercise or award.
• This summary is based on the Form 4 filing information; review the full SEC filing for additional legal footnotes or ownership details.